Reminder - Helios Multi-Sector High Income Fund (HMH) Goes Ex-Dividend Soon

Looking at the universe of stocks we cover at Dividend Channel, on 11/12/13, Helios Multi-Sector High Income Fund (HMH) will trade ex-dividend, for its monthly dividend of $0.0425, payable on 11/29/13. As a percentage of HMH's recent stock price of $5.96, this dividend works out to approximately 0.71%, so look for shares of Helios Multi-Sector High Income Fund to trade 0.71% lower — all else being equal — when HMH shares open for trading on 11/12/13.

START SLIDESHOW:
Click here to learn which 25 S.A.F.E. dividend stocks should be on your radar screen »

Below is a dividend history chart for HMH, showing historical dividends prior to the most recent $0.0425 declared by Helios Multi-Sector High Income Fund:

HMH+Dividend+History+Chart

In general, dividends are not always predictable; but looking at the history above can help in judging whether the most recent dividend from HMH is likely to continue, and whether the current estimated yield of 8.56% on annualized basis is a reasonable expectation of annual yield going forward.The chart below shows the one year performance of HMH shares, versus its 200 day moving average:

Helios Multi-Sector High Income Fund 200 Day Moving Average Chart

Looking at the chart above, HMH's low point in its 52 week range is $5.35 per share, with $6.62 as the 52 week high point — that compares with a last trade of $5.96.

In Friday trading, Helios Multi-Sector High Income Fund shares are currently up about 0.2% on the day.

null

More from Stocks

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

Week Ahead: Trade Fears and Stress Tests Signal More Volatility To Come

3 Great Stock Market Sectors Millennials Should Invest In

3 Great Stock Market Sectors Millennials Should Invest In

Why Millennials Are Ditching Stocks for ETFs

Why Millennials Are Ditching Stocks for ETFs

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Trump's 'Space Force' Could Launch a $1 Trillion Industry, Morgan Stanley Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says

Abiomed Stock Should Rise Some 12% From Here, Piper Jaffray Analyst Says